HRA000785
Title:
Aberrant m6A mRNA methylation in intratumoral C1Q+ Macrophages directs the T cell exhaustion and limits anti-tumor immune response
Release date:
2021-04-17
Description:
T cell dysfunction is a major barrier limiting the efficacy of cancer immunotherapies. However, the extrinsic cues orchestrating T cell dysfunction remain elusive. Here, we show C1q+ tumor-associated macrophages (TAMs), characterized by a unique N6-methyadenosine methylation program, engage in crosstalk with tumor-infiltrating CD8+ T cells. Single-cell RNA sequencing reveals that macrophage-specific knockout of Mettl14, a component of the m6A 'writer' complex, drives CD8+ T cell differentiation along a dysfunctional trajectory, ultimately impairing the capacity of these CD8+ T cells to eliminate tumors. Supporting the clinical relevance of these insights, we show that the Mettl14-m6A levels are negatively correlated with dysfunctional-T-cell levels in patients with colorectal cancer. Our study demonstrates how an m6A methylation writer in TAMs regulates CD8+ T cell dysfunction within tumors.
Data Accessibility:   
Open access
BioProject:
Study type:
Disease Study
Disease name:
colon cancer
Dataset Download
MetaData:
Files:
Aspera Command Line:  Help   

 Note: HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client) or Asepra Command Line.

Individuals & samples
Files
Submitter:   Han Dali / handl@big.ac.cn
Organization:   Beijing Institute of Genomics, Chinese Academy of Sciences
Submission date:   2021-04-17